Clinical trial
A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients…
NCT00042068 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00042068 |
|---|---|
| Title | A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis |
| Official title | A Multi-center, Double-Blind, Randomized, Parallel-Group Trial to Compare the Efficacy and Safety of Three Doses of Meloxicam (7.5, 15, and 22.5 mg) and Placebo in Patients With Rheumatoid Arthritis |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Arthritis, Rheumatoid |
| Intervention type | Drug |
| Interventions | Meloxicam |
| Enrollment | 1,000 |
| Start date | Jun 1, 2002 |
| Completion | Jul 1, 2003 |
| First posted | Jul 24, 2002 |
| Last update posted | Nov 1, 2013 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, France, Germany, Hungary, Italy, Russia, South Korea, Taiwan and 2 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: